MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/ane.13687

Медицинская библиотека · Acta neurologica Scandinavica · 2022

Miller Fisher syndrome following COVID-19 vaccines: A scoping review.

Kim Jee-Eun, Yoon Byeol-A, Kim Yoo Hwan, Kim Jong Kuk, Bae Jong Seok

СтатьяScoping ReviewПеревод пока не подготовлен

Аннотация

BACKGROUND AND PURPOSE: Miller Fisher syndrome (MFS), a variant of Guillain-Barré Syndrome (GBS), could be underestimated in evaluations of its adverse events (AEs) following COVID-19 vaccination. We aimed to identify and characterize MFS following COVID-19 vaccination.

MATERIALS AND

METHODS

Relevant studies reported on during the COVID-19 pandemic were identified in the MEDLINE, Embase, and other databases.

RESULTS

Nine cases of MFS following COVID-19 vaccination from various regions were included. Unlike MFS following COVID-19 infection, patients with MFS following COVID-19 vaccination frequently presented with anti-GQ1b antibody positivity (44%, 4/9). Unlike GBS following COVID-19 vaccination, only two of nine (22%) cases of MFS following COVID-19 vaccination had developed after viral-vector-related vaccine administration.

CONCLUSIONS

Miller Fisher syndrome following COVID-19 vaccination seems to have a different pathophysiology from MFS following COVID-19 infection and GBS following COVID-19 vaccination. This neurological syndrome with a rare incidence and difficulty in diagnosis should be considered an AE of COVID-19 vaccination.

Для цитирования: Kim Jee-Eun, Yoon Byeol-A, Kim Yoo Hwan, Kim Jong Kuk, Bae Jong Seok. Miller Fisher syndrome following COVID-19 vaccines: A scoping review.. Acta neurologica Scandinavica. 2022. DOI: 10.1111/ane.13687.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.